** Shares of biopharma firm Cara Therapeutics CARA.O rise 14.5% to $5.61
** Cara says that its board has approved a 1-for-3 reverse stock split, effective April 15
** Cara entered into a merger agreement with privately held Tvardi Therapeutics in December
** The stock split will be under the new name Tvardi Therapeutics Inc and symbol "TVRD" after the anticipated closing of the merger
** After the closing of the merger, the combined company's total outstanding shares are expected to be about 9.4 million
** As of last close, CARA had fallen 14.2% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。